You are here

  • Home
  • Online First
  • Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results

Article metrics

Article menu

other Versions

Download PDFPDF
Original Article
Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results

 

Online download statistics by month:

Online download statistics by month: January 2019 to December 2024

AbstractFullPdf
Jan 2019205128
Feb 2019464399
Mar 20195061511
Apr 201922847
May 2019135379
Jun 201920788
Jul 201911440
Aug 201911077
Sep 20199773
Oct 201910594
Nov 20198843
Dec 20198621
Jan 20207521
Feb 202011222
Mar 202013210
Apr 202029221
May 202017032
Jun 202032431
Jul 202037800
Aug 202026521
Sep 202020944
Oct 20205310
Nov 20206412
Dec 20208054
Jan 20216611
Feb 20215111
Mar 20219101
Apr 20214933
May 20212011
Jun 2021211
Jul 2021423
Aug 2021611
Sep 2021412
Oct 20214221
Nov 202110120
Dec 20218210
Jan 20226757
Feb 20229725
Mar 202219152
Apr 202211111
May 20229931
Jun 202213333
Jul 20229430
Aug 202221755
Sep 202215245
Oct 202213162
Nov 20229732
Dec 20229954
Jan 202310042
Feb 202313623
Mar 20238433
Apr 20238200
May 202393612
Jun 20239424
Jul 20235341
Aug 20235745
Sep 202311024
Oct 202310742
Nov 20239880
Dec 20239164
Jan 20242532
Feb 202414045
Mar 202411431
Apr 20246320
May 20247742
Jun 20248226
Jul 20245630
Aug 202411452
Sep 20248710
Oct 20247833
Nov 20247698
Dec 20241420
Total8536321209